Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07852780) titled 'Effect of Adjunctive Ursodeoxycholic Acid on Oxidative Stress, Inflammation, and Organ Dysfunction in Adults With Sepsis' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Tanta University
Condition:
Sepsis
Intervention:
Drug: Placbo
Recruitment Status: Not recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: October 1, 2026
Target Sample Size: 66
To know more, visit https://clinicaltrials.gov/study/NCT07852780
Published by HT Digital Cont...